Back to dashboard
CommercialCoverageLow impact

08.00.49f, Dofetilide (Tikosyn®) Use in the Inpatient Setting

Independence Blue Cross·Cardiology, Critical Care·Pharmacy
Effective date
Mar 5, 2025
We identified it
Jun 19, 2026
Days to comply
—

Summary

A commercial insurance policy regarding Dofetilide (Tikosyn®) use in inpatient settings has been reissued. This is a pharmacy-related policy update that will become effective March 5, 2025.

Action Required

Action needed
By March 5, 2025: Review the complete policy details at the provided URL to understand any changes to Dofetilide coverage or requirements for inpatient use. Update billing procedures if the policy affects drug administration or monitoring codes for this antiarrhythmic medication.

Related policy hubs